Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer
Authors
Matthew Mossanen (ORCID: https://orcid.org/0000-0001-5444-2515)
Oliver Jonas (ORCID: https://orcid.org/0000-0003-2512-2007)
Nobuhiko Hata (ORCID: https://orcid.org/0000-0002-6818-7700)
Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer
Matthew Mossanen, Oliver Jonas, Nobuhiko Hata, Christine Dominas et al.
Citations
2 citations
Journal
The Journal of Urology
Topics
Advanced MRI Techniques and Applications
Field-Weighted Citation Impact (FWCI)
0.81
article
Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer
Matthew Mossanen, Oliver Jonas, Nobuhiko Hata, Christine Dominas, Kemal Tuncali, Zuzana Tatárová, Sharath K. Bhagavatula, Juraj Jakubík, Sebastian W. Ahn, Benjamin V. Stone, Adam S. Kibel, Clare M. Tempany, Destiny Matthew, Daniella Furtado
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of UrologyVol. 213(2)
Institutions
Brigham and Women's Hospital (US), Harvard University (US), Medical University of South Carolina (US), Massachusetts General Hospital (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer — Matthew Mossanen, Oliver Jonas, et al. · The Journal of Urology (2024) | TGRS Research Map | TGRS